The volume fraction of MHC-II immunoreactive microglia was significantly decreased in the animals that received testosterone or oestradiol in both early and delayed treatments and in animals that received early dihydrotestosterone administration. In this study we have assessed the effect of early and late therapy with testosterone or its metabolites, oestradiol and dihydrotestosterone, on reactive astroglia and reactive microglia after a stab wound brain injury in orchidectomized Wistar rats. The first clinical trial by Voskuhl’s team, giving 10 men with relapsing-remitting MS a testosterone gel treatment, showed a shift in peripheral lymphocyte composition by decreasing the percentage of CD4+ T cells (TH1 phenotype) and by increasing natural killer (NK) cells 146,147,148.
Enhancing Neurological Health Through Testosterone Replacement Therapy When it comes to men's health, testosterone plays a crucial role in various bodily... TRT's Effect on Brain Plasticity and Learning Testosterone Replacement Therapy (TRT) is a medical treatment that has gained significant attention in recent... It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
The widely employed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) lesion mouse model of Parkinson’s disease (Meredith and Rademacher, 2011) was used to evaluate protective effects of allopregnanolone. In the substantia nigra (SN) of Parkinson’s disease patients, 5α-reductase type 1 and GABAA receptor subunits α4 and β1 were found to be downregulated, while 3α-HSD type 3 and GABAA receptor subunit α4 were upregulated in the cuneate nucleus (Luchetti et al., 2010). Demyelination is a major pathophysiological characteristic of disorders with neuroinflammatory components, such as MS, and potential roles for neurosteroids on myelination in the CNS have been investigated.
Two disorders that include both inflammatory and degenerative components are ALS and MS. As such, several studies have been performed in rodent models of these conditions in order to characterize protective effects of allopregnanolone. Allopregnanolone is a promising candidate for the treatment of conditions that present with both neuroinflammation and neurodegeneration, as it has been shown to protect against the molecular and neurotoxic consequences of both processes. In this study, treatment with allopregnanolone inhibited astrocytic and microglial ERK phosphorylation in the cuneate nucleus, concurrent with a reduction in pain hypersensitivity. In addition, protein markers for myelination of peripheral axons in the sciatic nerve have been found to be decreased by these treatments (Meyer et al., 2010). Because of their ability to modulate multiple signaling pathways, 3α-hydroxy, 5α-reduced neurosteroids have been shown to play important roles in physiological and pathophysiological regulation of stress, mood and feeding behavior (reviewed in Gunn et al., 2011; Mody and Maguire, 2012; Bäckström et al., 2014; Holmberg et al., 2018). Further work seems warranted in order to continue to identify and characterize mechanisms of action for these neurosteroids. Neurosteroids bind to a distinct site within the core of the ion channel at α- and β-subunit transmembrane domains, whereas GABA itself binds to a site that is between α and β subunits (Hosie et al., 2006).
In STZ-treated rats, treatment with PROG or its derivatives improves alterations in NCV, P0 and PMP22, Na+,K+-ATPase activity, thermal threshold and skin innervation density and counteracts the increase in the number of fibers with myelin infoldings . Furthermore, in guided regeneration of the rabbit facial nerve, PROG treatment increases the number of Schwann cell nuclei, of nonmyelinated and myelinated nerve fibers (also with an increase in their diameters), as well as of the g-ratio of myelinated nerve fibers . These effects of PROG and its derivatives seem to be a peculiarity of this class of neuroactive steroids because neither T nor its derivatives were able to influence the morphological parameters analyzed in these experiments 15,20. Interestingly, in these experimental models the levels of neuroactive steroids were changed in a sex-dimorphic manner by the pathology. Changes in the levels of neuroactive steroids have also been reported in an experimental model of Charcot–Marie–Tooth type 1 (CMT1A) and in experimental diabetic neuropathy 35,36.
In the same study, allopregnanolone partially protected striatal neuronal-glial co-cultures against neurotoxicity and intracellular calcium accumulation induced by Tat treatment. Allopregnanolone has also been shown to protect against molecular and functional aspects of neuropathic pain induced by median nerve chronic constriction injury (CCI) in male Sprague-Dawley rats (Huang et al., 2016). These effects were restored to normal by treatment with progesterone, 5α-dihydroprogesterone (DHP), or allopregnanolone (Meyer et al., 2010, 2011), with the precursors conceivably achieving these effects at least in part through conversion to allopregnanolone.